CLAREMONT, Calif., March 25, 2019 /PRNewswire/ — Researchers have found multiple applications for the CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats) gene editing technology since it came into use by the scientific community. Ke… […]
Charge Density Mapping Transforms Understanding of Atrial Arrhythmias
CARLSBAD, Calif., March 25, 2019 /PRNewswire/ — Acutus Medical today announced the publication of “High Resolution Non-Contact Charge Density Mapping of Endocardial Activation” in… […]
SAN DIEGO, March 21, 2019 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing proprietary liquid biopsy tests that provide clinically actionable information to physicians to improve cancer tre… […]
VANCOUVER, British Columbia and SAN DIEGO, March 21, 2019 /PRNewswire/ — Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced today the appoint… […]
BioMed Realty also closes a $430 million financing on the first phase of Gateway of Pacific after executing a long-term lease with AbbVie Inc. for 480,000 square feet
SAN DIEGO, March 20, 2019 /PRNewswire/ — BioMed Realty, a Blackstone portfolio co… […]
New study in JNCCN finds 21-gene assay was associated with savings of approximately $3,600 per patient in chemotherapy costs alone for people with clinically high-risk breast cancer.
PLYMOUTH MEETING, Pa., March 19, 2019 /PRNewswire/ — New research … […]
The Company Appoints Jean-Michel Vernier, Ph.D., as Vice President of Chemistry and adds Val Harding, Ph.D., to the Board of DirectorsThe Company Also Announces its Executive Chairman and Co-Founder, Jonathan E. Lim, M.D., Has Transitioned into the Rol… […]
LA IVF adds fourth location in Southern California, bringing successful, customized fertility treatments to local and international patients
LOS ANGELES, March 18, 2019 /PRNewswire/ — LA IVF Clinic (LAIVF) opened doors to its fourth clinic in March,… […]
Biocept expands intellectual property position to 32 issued patents globally for its highly sensitive methods for detecting cancer biomarkers in blood and other specimen types
SAN DIEGO, March 18, 2019 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a … […]
LA JOLLA, Calif., March 15, 2019 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced the resignation of Dr. Timot… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
